Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Medical Decision Analysis: Choosing Second Line Treatment in Adults with Immune Thrombocytopenia (ITP)

Barbara Skopec, MD PhD, Hollenberg P. James, MD, James B. Bussel, MD

Blood (2018) 132 (Supplement 1): 4986.

https://doi.org/10.1182/blood-2018-99-120346

Published: 2018

Journal Articles

Which Patients with Myelofibrosis Should Receive Allogeneic Stem Cell Transplantation? A Decision Analysis Based on the Systematic Review of 4,341 Patients

Monia Marchetti, MD, Nicolaus Kroeger

Blood (2017) 130 (Supplement 1): 3301.

https://doi.org/10.1182/blood.V130.Suppl_1.3301.3301

Published: 2017

Journal Articles

A Decision Model to Estimate Risk Thresholds for Guiding Duration of Anticaogulation in Unprovoked Venous Thromboembolism

Faizan Khan, BSc, Kednapa Thavorn, MPharm, PhD, Doug Coyle, MA, MSc, PhD, Marc A Rodger, MD MSc, FRCPC

Blood (2017) 130 (Supplement 1): 4641.

https://doi.org/10.1182/blood.V130.Suppl_1.4641.4641

Published: 2017

Journal Articles

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Abi Vijenthira, MD, Matthew C Cheung, MD, Chai Wye Phua, MD, Kelvin Chan, Joanna Graczyk, MD, Rena Buckstein, MD, Anca Prica, MD

Blood (2016) 128 (22): 1183.

https://doi.org/10.1182/blood.V128.22.1183.1183

Published: 2016

Journal Articles

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

Martine Extermann, MD PhD, Marina Sehovic, MD MPH, Tea Reljic, MPH, Jongphil Kim, PhD, Jeffrey E. Lancet, MD, Benjamin Djulbegovic, MD PhD

Blood (2016) 128 (22): 3998.

https://doi.org/10.1182/blood.V128.22.3998.3998

Published: 2016

Journal Articles

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

Varun C Dhulipala, MD, Martine Extermann, MD PhD, Najla Al Ali, Jongphil Kim, Marina Sehovic, MD MPH, Tea Reljic, Benjamin Djulbegovic, MD PhD, Jeffrey E Lancet, MD

Blood (2015) 126 (23): 2505.

https://doi.org/10.1182/blood.V126.23.2505.2505

Published: 2015

Journal Articles

A Markov Model of Phase I Clinical Trials before or after Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

Ehsan Malek, MD, Yihong Deng, MS, Mark Eckman, MD, Jeffrey Weldge, PhD, James J. Driscoll, MD PhD

Blood (2015) 126 (23): 3170.

https://doi.org/10.1182/blood.V126.23.3170.3170

Published: 2015

Journal Articles

Is Idelalisib Cost-Effective for Refractory/Relapsed Chronic Lymphocytic Leukemia? a Decision Analysis in the Second-Line Setting

Monia Marchetti, MD PhD, Antonio Cuneo, Francesca Romana Mauro, MD PhD, Marco Montillo, MD, Elisa Martelli, Maria Paola Pedone

Blood (2015) 126 (23): 3305.

https://doi.org/10.1182/blood.V126.23.3305.3305

Published: 2015

Journal Articles

Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Revised International Prognostic Scoring System (IPSS-R)

Matteo Giovanni Della Porta, Emilio Paolo Alessandrino, MD, Christopher H Jackson, Cristiana Pascutto, PhD, Andrea Bacigalupo, MD, Luca Malcovati, MD, Maria Teresa Van Lint, MD, Bernardino Allione, Massimo Bernardi, MD, Francesco Onida, MD, Stefano Guidi, Anna Paola Iori, MD, Raffaella Cerretti, MD, Paola Marenco, MD, Pietro Pioltelli, Emanuele Angelucci, Alberto Bosi, MD, Mario Cazzola, MD, Alessandro Rambaldi, MD

Blood (2014) 124 (21): 531.

https://doi.org/10.1182/blood.V124.21.531.531

Published: 2014

Journal Articles

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Blood (2014) 124 (21): 1221.

https://doi.org/10.1182/blood.V124.21.1221.1221

Published: 2014

Journal Articles

Cranial Radiation for Pediatric T-Cell Acute Lymphoblastic Leukemia: A Decision Analysis

Michael J. Kelly, MD MPH, MS, Stephen G. Pauker, MD, Susan K. Parsons, MD MRP

Blood (2014) 124 (21): 3700.

https://doi.org/10.1182/blood.V124.21.3700.3700

Published: 2014

Journal Articles

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Jasmin Lacevic, Tea Reljic, BS, Najla El Jurdi, MD, Mohamed A Kharfan-Dabaja, MD, Taiga Nishihori, MD, Rami S. Komrokji, MD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 5372.

https://doi.org/10.1182/blood.V122.21.5372.5372

Published: 2013

Journal Articles

Elevation of CRP Precedes Bloodstream Infections in Patients Undergoing Hematopoietic Cell Transplantation – a Case-Control Study.

Ron Ram, M.D, Moshe Yeshurun, MD, Laura Farber, Leonard Leibovici, MD, Corina Herscovici, MD, Ofer Shpilberg, MD, MPH, Mical Paul, MD

Blood (2012) 120 (21): 3026.

https://doi.org/10.1182/blood.V120.21.3026.3026

Published: 2012

Journal Articles

Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)

Shahrukh Hashmi, MD, MPH, Chintan Pandya, MD MPH, Morie A Gertz, M.D., Angela Dispenzieri, MD, William Hogan, MD, Mustaqeem A Siddiqui, MD, Nandita Khera, MD, Katia Noyes, MS MPH PhD, Shaji K. Kumar, MD

Blood (2012) 120 (21): 602.

https://doi.org/10.1182/blood.V120.21.602.602

Published: 2012

Journal Articles

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Blood (2011) 118 (21): 115.

https://doi.org/10.1182/blood.V118.21.115.115

Published: 2011

Journal Articles

Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Who Classification-Based Prognostic Scoring System (WPSS)

Blood (2011) 118 (21): 116.

https://doi.org/10.1182/blood.V118.21.116.116

Published: 2011

Journal Articles

Cost-Effectiveness of Double-Unit Cord Blood Transplantation Versus Single-Unit Cord Blood Transplantation in Adult Patients with Acute Leukaemia in France- On Behalf of SFGM-TC, Eurocord, ALWP-EBMT

Myriam Labopin, MD, MS, Annalisa Ruggeri, MD, Namik Taright, Federico Garnier, MD, Catherine Faucher, MD, Anne-Gaelle Le Coroller, Noel-Jean Milpied, MD, Didier Blaise, MD, Manuela Badoglio, Mohamad Mohty, Agnes Buzyn, Fernanda Volt, Eliane Gluckman, MD, PhD, Norbert C Gorin, Vanderson Rocha, MD, PhD

Blood (2011) 118 (21): 3130.

https://doi.org/10.1182/blood.V118.21.3130.3130

Published: 2011

Journal Articles

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, Naoyuki Uchida, Heiwa Kanamori, Kensuke Usuki, Takuya Yamashita, Masato Watanabe, Kazuaki Yakushiji, Shingo Yano, Yuichiro Nawa, Jun Taguchi, Jin Takeuchi, Junji Tomiyama, Yuko Nakamura, Ikuo Miura, Yoshinobu Kanda, Yoichi Takaue, Takahiro Fukuda

Blood (2011) 117 (7): 2113–2120.

https://doi.org/10.1182/blood-2010-05-285502

Published: 2011

Includes: Supplemental data

Journal Articles

HLA Alloantibody Persistence and De Novo Production of HLA Alloantibodies of Donor Origin Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Ross M Fasano, MD, Sharon Adams, Aleah Smith, Theresa Donohue, MS, PA-C, Charles D. Bolan, Jr., MD, Kyoko Sugimoto, MD, PhD, Willy A. Flegel, MD, Richard Childs, MD

Blood (2010) 116 (21): 1109.

https://doi.org/10.1182/blood.V116.21.1109.1109

Published: 2010

Journal Articles

G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision Analysis.

Joanna Graczyk, MD, Matthew Cheung, MD, Rena Buckstein, Kelvin Chan, MD

Blood (2010) 116 (21): 3831.

https://doi.org/10.1182/blood.V116.21.3831.3831

Published: 2010

NARROW

Medical Decision Analysis: Choosing Second Line Treatment in Adults with Immune Thrombocytopenia (ITP)

Which Patients with Myelofibrosis Should Receive Allogeneic Stem Cell Transplantation? A Decision Analysis Based on the Systematic Review of 4,341 Patients

A Decision Model to Estimate Risk Thresholds for Guiding Duration of Anticaogulation in Unprovoked Venous Thromboembolism

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

A Markov Model of Phase I Clinical Trials before or after Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

Is Idelalisib Cost-Effective for Refractory/Relapsed Chronic Lymphocytic Leukemia? a Decision Analysis in the Second-Line Setting

Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Revised International Prognostic Scoring System (IPSS-R)

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Cranial Radiation for Pediatric T-Cell Acute Lymphoblastic Leukemia: A Decision Analysis

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Elevation of CRP Precedes Bloodstream Infections in Patients Undergoing Hematopoietic Cell Transplantation – a Case-Control Study.

Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Who Classification-Based Prognostic Scoring System (WPSS)

Cost-Effectiveness of Double-Unit Cord Blood Transplantation Versus Single-Unit Cord Blood Transplantation in Adult Patients with Acute Leukaemia in France- On Behalf of SFGM-TC, Eurocord, ALWP-EBMT

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

HLA Alloantibody Persistence and De Novo Production of HLA Alloantibodies of Donor Origin Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only